Ross Leonard S 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Mar 21, 2019
Insider Transaction Report
Form 4
Ross Leonard S
Corporate Controller
Transactions
- Tax Payment
Common Stock
2019-03-19$2.47/sh−1,735$4,285→ 74,452 total
Footnotes (2)
- [F1]No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units
- [F2]Reflects the last reported sale price for the Registrant's shares of common stock on the Nasdaq Global Market on March 19, 2019